Salt Capital and Proparco acquire Namibian Oncology Centre
The deal brings a new ownership structure to one of Namibia’s key private oncology providers.
** For the best experience, download the free Africa Private Equity News app Android | iOS **
Salt Capital and Proparco, the French development finance institution, have acquired The Namibian Oncology Centre (NOC), a specialist cancer care provider in Namibia.
Founded by Namibian clinicians, healthcare professionals and local businesspeople, NOC has played an important role in expanding access to cancer diagnosis, treatment and care in the country.
Jan Bosch, managing partner of Salt Capital, commented: “The Namibian Oncology Centre plays a critical role in the country’s healthcare ecosystem. We are honoured to have been chosen by the founders as the new long-term partners of NOC, and we approach this investment with humility and responsibility. Our focus is on supporting the centre’s mission, strengthening healthcare standards, and contributing meaningfully to cancer awareness and access to care in Namibia.”
Johann Choux, regional director for Southern Africa and the Indian Ocean at Proparco, said: “By supporting The Namibian Oncology Centre, we are contributing to expanding access to high-quality oncology care and strengthening cancer awareness. This project aligns with our 2023-2027 strategy: partnering with local players to deliver concrete impact, particularly by reducing inequalities in access to essential services, while supporting the sustainability and quality of care in developing countries.”
Want to know who is raising, investing, and exiting in Africa? Get Africa Private Equity News’ monthly Dealmaker’s Log – a database of reported investment deals, exits, and fundraising closes. Subscribe now